Home › approves
 

Keywords :   


Tag: approves

Court approves first-of-its-kind data breach settlement

2014-03-18 12:40:14| InfoWorld: Top News

Courts have generally tended to dismiss consumer class-action lawsuits filed against companies that suffer data breaches if victims can't show that the the breach directly caused a financial hit. A federal court in Florida broke the mold by approving a $3 million settlement for victims of a data breach in which personal health information was exposed when multiple laptops containing the unencrypted data were stolen.

Tags: data court settlement breach

 

US: Sears Holdings board approves Lands' End spin-off

2014-03-17 13:20:00| Daily apparel & textile news and comment - from just-style.com

The board of Sears Holdings has approved a deal to spin off the company's Lands' End clothing business, which it acquired more than ten years ago.

Tags: end board lands holdings

 
 

Florida DOT Approves Use of Polypropylene Pipe

2014-03-17 09:09:12| chemicalonline Home Page

Advanced Drainage Systems, Inc. (ADS) announced today that the Florida Department of Transportation (FDOT) has approved the use of ADS’ High Performance (HP) polypropylene (PP) pipe in 12 through 60 inch diameters for 100-year design service life applications in accordance with FDOT’s 2014 Standard Specifications for Road and Bridge Construction, Section 948-7

Tags: approves

 

FDA Approves Merck's NOXAFIL (posaconazole) Injection (18 mg/mL) for Intravenous Use

2014-03-15 04:54:54| Biotech - Topix.net

Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL injection , a new formulation of NOXAFIL for intravenous use.

Tags: use injection fda approves

 

FDA Approves Mercks NOXAFIL (posaconazole) Injection (18 mg/mL) for Intravenous Use

2014-03-14 18:40:00| Merck.com - Product News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use. Mercks antifungal agent is also marketed as NOXAFIL (100 mg) delayed-release tablets and NOXAFIL (40 mg/mL) oral suspension. Language: English Contact: MerckMedia:Pam Eisele, (267) 305-3558Robert Consalvo, (908) 423-6595orInvestor:Carol Ferguson, (908) 423-4465Justin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: use injection fda approves

 

Sites : [266] [267] [268] [269] [270] [271] [272] [273] [274] [275] [276] [277] [278] [279] [280] [281] [282] [283] [284] [285] next »